Geron

4 followers

‌

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.


Org chart

Michelle Robertson
Executive Vice President, CFO & Treasurer
Melissa A. Kelly Behrs
EVP, Business Operations & Chief Alliance Officer
Scott Hutson
Vice President Of Sales
Ryan Vincenti
Associate Director Of Commercial Excellence
Tj McLaughlin
Senior Director, Global Pricing And Contracting
Jr Raelin
Senior Director - Commercial Operations, Data And Technology
Stewart Hackney
Senior Director; Market Access

Board & advisors